China’s Sinopharm says data ‘better than expected” from unit’s COVID-19 vaccine trials

China National Pharmaceutical Group (Sinopharm) said on Wednesday the data from large-scale, late-stage clinical trials for its unit’s COVID-19 vaccine are “better than expected”.
( read original story …)